| Theravance Receives Complete Response Letter on the Telavancin NDA for the ... - CNNMoney.com (press release) |
|
|
CNNMoney.com (press release)New onset or worsening renal impairment occurred in patients who received VIBATIV. Renal adverse events were more likely to occur in patients with baseline ... read more |